Hiroshi Tanizaki
Hiroshi Tanizaki publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Pancreatic and Hepatic Oncology Research, Gastric Cancer Management and Outcomes and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #6,759,039 of 7,710,434 ranked researchers
- Rank in Japan
- #285,083 of 383,136
- Works
- 15
- Citations
- 133
- Citations per work
- 8.9
What does Hiroshi Tanizaki research?
Hiroshi Tanizaki's work is mostly in Medicine (84%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1384.5%
- Medicine1384.5%
- Everything else215.5%
- 1Surgery27% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Oncology11% of their works
- 4Hepatology9% of their works
- 5Radiology, Nuclear Medicine and Imaging9% of their works
- 6Epidemiology7% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Amoebic Infections and Treatments
- Gallbladder and Bile Duct Disorders
Which keywords describe Hiroshi Tanizaki's research?
The keywords of their largest research topics: Epidemiology, Chemotherapy, Treatment, Cholangiocarcinoma, Clinical Practice Guidelines, Surgical Management, Diagnosis and Immune Response.
- pyogenic liver abscess
- Ribavirin
- Imatinib Mesylate
- Hepatitis C Virus
- ERCP
- Surgical Complications
- Intrahepatic Cholangiocarcinoma
- Endoscopic Resection
- Immune Response
- Surgical Management
- Cholangiocarcinoma
- Chemotherapy
- Epidemiology
- Treatment
- Clinical Practice Guidelines
- Diagnosis
- Biliary Tract Cancer
- Gastric Cancer
- Pancreatic Cancer
- Cholecystitis
- Entamoeba histolytica
- Hepatocellular Carcinoma
- Liver Cancer
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Epidemiology73 topics
- Chemotherapy62 topics
- Treatment63 topics
- Cholangiocarcinoma52 topics
- Clinical Practice Guidelines52 topics
- Surgical Management52 topics
- Diagnosis42 topics
- Immune Response42 topics
- Biliary Tract Cancer31 topic
- Endoscopic Resection31 topic
- Gastric Cancer31 topic
- Intrahepatic Cholangiocarcinoma31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
- Cholecystitis21 topic
- ERCP21 topic
- Entamoeba histolytica21 topic
- Hepatitis C Virus21 topic
- Hepatocellular Carcinoma21 topic
- Imatinib Mesylate21 topic
- Liver Cancer21 topic
- Ribavirin21 topic
- Sunitinib21 topic
- pyogenic liver abscess21 topic
Where does Hiroshi Tanizaki work?
Hiroshi Tanizaki's main affiliation in the publication record is National Cancer Center Hospital East, Japan.
How many publications and citations does Hiroshi Tanizaki have?
OpenAlex counts 15 works and 133 citations for Hiroshi Tanizaki, an h-index of 5, ranking #6,759,039 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroshi Tanizaki. Posts are plain text and can be reported.